Rich leads Arent Fox’s Hatch-Waxman litigation team, which has represented generic pharmaceutical companies in dozens of lawsuits over the past decade, including several high-profile, first-to-file suits.  Rich has also litigated cases in the technical fields of biotechnology, diagnostic devices, and herbal supplements.

Rich advises chemical, pharmaceutical, and medical device companies on the acquisition, sale, in-licensing, and out-licensing of intellectual property.  Rich also advises manufacturing companies in the design-around process, including patent landscape and freedom-to-operate analyses.

Rich’s patent prosecution team counsels clients in a wide variety of technologies, such as new chemical entities, medical and diagnostic devices, polymers, functional foods, herbal extracts, drug delivery systems, gene therapy, transgenic animals and plants, vaccines, antibodies, and imaging agents.

• “Freedom To Operate Analysis: Managing Client’s Expectations,” Freedom To Operate, American Conference Institute; July 30, 2012
• “Exploring the Link Between FDA Approval and Drug Patenting,” Hatch-Waxman Boot Camp, American Conference Institute; June 25, 2012
• “Patent Challenge Strategies for ANDA Applicants,” Paragraph IV Disputes, American Conference Institute; April 24, 2012
• “The Paragraph IV Notice Letter: View From the Generic Side,” Paragraph IV Disputes, American Conference Institute; May 3, 2011
• “Pre-Litigation Patent Strategy for Generic Drug Manufacturers,” Paragraph IV Disputes, American Conference Institute; April 27, 2010
• “Outside Counsel: Your Due Diligence Traffic Cop,” Pharma/Biotech IP Due Diligence, American Conference Institute; January 28, 2009
• “Pre-Litigation Patent Strategy for Generic Drug Manufacturers,” Paragraph IV Disputes, American Conference Institute; April 30, 2008
• “Identifying and Protecting Your Innovations,” Pharma/Biotech Patent Claim Drafting and Prosecution, American Conference Institute; February 25, 2008
• “Perfecting Claims In Life Sciences Patent Applications,” Pharma/Biotech Patent Boot Camp, American Conference Institute; September 18, 2007
• “Patent Challenges Post-MMA,” FDA Regulatory and Compliance Symposium; August 23, 2007
• “Perfecting Claims In Life Sciences Patent Applications,” Pharma/Biotech Patent Boot Camp, American Conference Institute; June 22, 2007
• “Best Practices – Keeping Tabs On In-House IP,” The Business of Intellectual Property Conference, Technology Council of Maryland; May 17, 2007
• “ANDA Applicants’ Pre-Litigation Strategy: Tips From the Front Line,” Paragraph IV Disputes, American Conference Institute; April 23, 2007
• “In-Licensing Technology: Lessons Learned,” Patent Portfolio Management, American Conference Institute; February 28, 2007
• “Introduction to Patent Rights,” The Business of Intellectual Property Conference, Technology Council of Maryland; January 10, 2007